Kantaro Biosciences partners with Bio-Techne for manufacturing and global kit distribution; Scaled kit production to enable clinical laboratories to conduct 10M tests per month is planned to begin in July Mount Sinai Health System (“Mount Sinai”) and RenalytixAI (LSE: RENX) today announced …

Today, the Mount Sinai Laboratory (MSL), Center for Clinical Laboratories received emergency use authorization from the U.S. Food and Drug Administration (FDA) for an antibody test that was developed, validated, and launched at Mount Sinai by a team of internationally renowned researchers …

Collaboration combines Harbour BioMed’s proprietary H2L2 Harbour Mice® platform for fully human monoclonal antibody generation with Mount Sinai’s translational medical research expertise. NEW YORK, NY, CAMBRIDGE, MA, ROTTERDAM, NL, and SUZHOU, CN – Mount Sinai Health System and Harbour BioMed (HBM) have …

Tacitus Therapeutics exclusively licenses technology for expansion, differentiation and engineering of hematopoietic stem cells for use in therapeutic applications Tacitus Therapeutics, a clinical-stage company, has launched in collaboration with the Mount Sinai Health System to develop stem cell therapies initially targeting blood …

Nines’ unique approach to teleradiology reimagines radiology together with engineering and data science prowess to bring a new level of patient care Nines debuts as the first-of-its-kind teleradiology practice that combines top quality radiologists and world-class engineering to deliver high-quality diagnostics and …

The Human Immune Monitoring Center (HIMC) at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo® (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi. While …

Clinic and research lab offers patients access to comprehensive health assessment, expands clinical understanding of disease prevention and provides wealth of health outcomes data Onegevity Health, LLC, a New York City-based health technology company focused on biometric data, artificial intelligence and personalized …

Opportunity to support digital health platform for Inflammatory Bowel Disease September 10, 2019 ⁠— EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that it has entered into a non-exclusive Preferred Partner Arrangement with Mount Sinai Innovation Partners (MSIP).  MSIP is …

Provides Priority Regulatory Review of AI-Enabled Diagnostic for Fast-Progressing Kidney Disease NEW YORK, May 2, 2019 /PRNewswire/ – Renalytix AI plc (RENX.L), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today that it has been granted Breakthrough Device designation by the U.S. Food …

$60.75M funding round led by ARCH Venture Partners with 6 Dimensions Capital HiberCell will build on pioneering tumor dormancy research conducted by the Julio Aguirre-Ghiso Lab at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai HiberCell, a …